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EXPERIENCES WITH METHOXSALEN IN THE AMERICAN TROPICS
MARK T. HOEKENGA, M.D.'
The dermatologic potentialities of methoxsalen
in populations living in the tropics are especially
intriguing for several reasons. The nationals of
tropical countries tend to be more or less darkly
pigmented; in them such physically innocuous
processes as vitiligo may have serious social and
economic impact. White-skinned residents may
be subject to greater actinic dermal injury than
would be the case in their normal, temperate
climates. Finally, the optimal source of ultra-
violet energy (i.e., intense natural sunlight) is
readily available.
While the mode of action of the furocoumarins
is not entirely clear, it has been shown that
systemic administration of appropriate doses of
methoxsalen followed by ultraviolet radiation
will produce a series of morphologic changes in
skin (1, 2). The stratum corneum thickens and a
structure resembling stratum lucidum may ap-
pear within two weeks of daily exposures; there
is a possibility this may be intimately related to
the stratum corneum conjunctum of Szakall (3).
Although more work remains to be done on the
relation of altered structure to altered function,
Imbrie et at. (4) have clearly demonstrated that a
single ultraviolet exposure of methoxsalen-
conditioned skin nearly doubles the amount of
energy required to induce a minimal erythema
in the treated area five to six weeks later.
Another change has to do with melanin pigmen-
tation, which may become increased (as com-
pared to skin areas exposed to ultraviolet without
methoxsalen). Two explanations have been of-
fered. The first, which seems to be the case in
normal skin, is that the altered epidermis simply
increases retention of melanin formed in ordinary
amounts in response to sunlight. The second
suggestion, that the melanocytes are somehow
stimulated to increased production of melanin,
seems to have application in one abnormal condi-
tion, vitiligo. This is a disease characterized by
failure of pigmentation in areas of skin containing
a normal complement of melanocytes, twice the
normal amount of sulfhydryl, tyrosinase, and
ample substrate, tyrosine (4). The reason for loss
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of function of the tyrosinase system in these
melanocytes is unclear, as is the exact mode of
action of methoxsalen-ultraviolet in correcting
it.
It is the purpose of this report to present pre-
liminary data bearing on the clinical aspects of
these problems.
MATERIAL AND METHOD
Thirty-five individuals, ranging in age from 15
to 39 years of age, resident in or near Poerto
Armuelles which is located in Panama adjacent to
the Costa Rican border, were included. Twenty
were females, fifteen were males. Only ten were
more or less pure Caucasian. The other 25 were
mestizos of mixed Spanish, Indian and, uncom-
monly, Negro ancestry. Twenty-four had some
degree of vitiligo. The remainder simply desired a
protective suntan. The study was carried out dur-
ing the dry season when several hours of intense
sunshine were available daily.
Each subject was given a bottle of 30 protection
coated methoxsalent tablets containing 10 mg. of
active crystalline drug per tablet. Direction sheets
and questionnaires were issued in English or
Spanish, to the effect that two tablets should be
taken daily for 15 days, preferably after a meal or
with a glass of milk, and that approximately two
hours later the skin should be exposed to sunlight
for 20—30 minutes.
RESULTS
Increased solar tolerance. Five individuals re-
ported a suntanning effect on the first or second
day of treatment but the remainder were con-
scious of darkening only on the third day and
thereafter. This feature was difficult to quanti-
tate, and in the absence of controls, it would be
unscientific to report that the effects seen were
greater than might have been the case following
similar exposures without the drug.
Vitiligo. Several mild cases of vitiligo "disap-
peared" or became inapparent by the fifteenth
day. Marked cases all showed some degree of
repigmentation. In several who exposed their
skin to sunlight for the maximum of 30 minutes,
there was intense erythema, but in no instance
* The trade name for methoxsalen, Upjohn, is
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did blistering of the skin occur. Subjective dis-
comfort in these reddened areas was distinctly
less than an observer might expect. In spite of
limited cosmetic improvement in a number of
patients with extensive vitiliginous areas, all 24
subjects were pleased.
After an interval of thirty days, five of these
vitiligo patients were re-treated with an identical
course of methoxsalen. This group included two
persons who believed that they had experienced
a slight recrudescence of vitiligo. In each of these
five, some additional repigmentation was experi-
enced.
Side effects. Ten patients reported some degree
of nausea, usually within 15 minutes after taking
the tablets, but none vomited. All except one,
however, were able to complete the 15-day course.
The exception, a fair-skinned blond woman of 34
years, developed a persistent nausea on about the
eighth day. This lasted for four days after medi-
cation was suspended. In spite of this, she was
quite satisfied with the treatment because of the
tan she acquired easily and quickly and because a
dozen or more hypopigmented spots became map-
parent.
DISCUSSION
Aside from the cosmetic features of suntanning,
which vary according to whims of fashion the
complex of skin changes involved represents
Nature's attempt to shield the living parts of the
skin from solar insult. The erythema of sunburn
reflects actinic injury to the deeper cellular
layers of the epidermis, and possibly even the
dermis. The normal reaction of protection,
"suntanning", depends on the capacity of the
skin to undergo changes similar to those de-
scribed by Becker, Jr. (1). It would seem reason-
able to think that measures which would acceler-
ate or augment these self-preservative changes
would be desirable, if they are specific and not
inherently injurious to other organ systems.
In the dark skinned races there is apparently
considerable protection "from the start", and in
spite of lifelong exposure to sun, wind, drying,
and other factors causing skin weathering, pri-
mary carcinoma of that organ, including mela-
nomas (6, 7), is uncommon in them at all ages.
The association between sunlight (actinic insult)
and skin cancer in light skinned races is well
documented (8). From data presently available it
seems that methoxsalen plus ultraviolet energy,
even single solar exposures (4), or after repeated
suberythemal exposures to artificial sources of
ultraviolet (1), may so alter the skin that solar
tolerance is markedly increased. This is apparent
within one week (4) and may persist for months.
It is not due entirely to pigmentation. This is in
keeping with the fact that increased solar tolerance
has been induced in albinos who cannot form
melanin. Whatever the mechanisms, these mor-
phologic and functional changes would seem to be
desirable, self-protective ones for light complected
residents in tropical and other sunny areas.
Reports are conflicting concerning results of
methoxsalen in the treatment of vitiligo. It is
significant, however, that results seem to be
more and more encouraging as one approaches
the equator. Intense natural sunlight appears to
produce changes which cannot be completely
duplicated by presently available artificial sources
of photomagnetic energy.
It should also be pointed out that many reports
are given in terms of the investigator's evaluation
of percentage repigmentation or similar criteria.
It is important not to lose sight of the fact that
the cardinal objective of treatment is to improve
the appearance and social acceptability of the
patient, as he evaluates it. The majority of sub-
jects in this study, for example, still have obvious
vitiligo, but were pleased and encouraged by the
early changes they observed. All of these wished
to extend treatment further.
SUMMARY
Thirty-five individuals living in a hot, humid
Pacific coast area of western Panama were
treated with a 15-day oral regimen of 20 mg. of
methoxsalen daily followed by measured expo-
sures to sunlight. Twenty-four had vitiligo of
some degree and all were improved. The repig-
mentation appeared to be complete in a few mild
cases but only partial in the majority. A second
course in five of the latter induced further re-
pigmentation.
Suntanning was apparent in most of the light
skinned patients only on the third day and
thereafter. Because controls were not used, it is
not possible to compare this effect with the
results of similar solar exposures without the
drug. Reasons have been given that point up the
desirability of these self-protective changes in
such residents of tropical areas.
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